ArticleCPT: pharmacometrics & systems pharmacology2025

A Novel Empirical Autoinduction Model to Characterize the Population Pharmacokinetics and Recommend Dose for Repotrectinib in Adult and Adolescents With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements.

Shengnan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.